Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 6 USDMF, 3 CEP/COS, 2 JDMF, 6 KDMF, 1 NDC API, 2 Listed Suppliers, $ API Reference Price

11 API Suppliers
6 USDMF
3 CEP/COS
2 JDMF
6 KDMF
1 NDC API
2 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 5 FDA Orange Book, 1 South Africa

6 FDF Dossiers
5 FDA Orange Book
1 South Africa

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 8 Actylis, 1 BASF, 1 Finar, 4 Gangwal Chemicals, 1 Kerry, 1 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pluviaendo, 6 Seppic

relatedExcipients
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
8 Actylis
1 BASF
1 Finar
4 Gangwal Chemicals
1 Kerry
1 Microlex e.U
1 Nanjing Bold Chemical
1 Pluviaendo
6 Seppic

EXCIPIENTS BY APPLICATIONS

14 Parenteral, 10 Solubilizers, 4 Topical, 3 Emulsifying Agents, 3 Film Formers & Plasticizers, 2 Surfactant & Foaming Agents, 2 Thickeners and Stabilizers, 1 Fillers, Diluents & Binders, 1 Coating Systems & Additives, 1 Taste Masking, 1 API Stability Enhancers, 1 Controlled & Modified Release, 1 Direct Compression, 1 Co-Processed Excipients, 1 Rheology Modifiers

excipientsByApplications
14 Parenteral
10 Solubilizers
4 Topical
3 Emulsifying Agents
3 Film Formers & Plasticizers
2 Surfactant & Foaming Agents
2 Thickeners and Stabilizers
1 Fillers, Diluents & Binders
1 Coating Systems & Additives
1 Taste Masking
1 API Stability Enhancers
1 Controlled & Modified Release
1 Direct Compression
1 Co-Processed Excipients
1 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 31 NEWS #PharmaBuzz

media
1 DATA COMPILATION #PharmaFlow
31 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 Annual Reports

globalSalesInformation
3 Annual Reports

MARKET PLACE

9 APIs, 3 FDF Dossiers

marketPlace
9 APIs
3 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

otherSolutions
2 EDQM

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 428

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

27DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

2,474

Finished Drug Prices

26 RELATED EXCIPIENT COMPANIES

46EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 88755-39-9, Chembl2000337, Runx1/eto tetramerization-in-1, Nsc162496, Schembl16211954, Dtxsid40864143

Molecular Formula

C₁₈H₁₄O₇

Molecular Weight

342.3 g/mol

InChI Key

PPEBBOHQEAQKSW-UHFFFAOYSA-N

1 2D Structure

Hyaluronidase

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2,4-bis(1,3-benzodioxol-5-yl)-4-oxobutanoic acid

2.1.2 InChI

InChI=1S/C18H14O7/c19-13(11-2-4-15-17(6-11)25-9-23-15)7-12(18(20)21)10-1-3-14-16(5-10)24-8-22-14/h1-6,12H,7-9H2,(H,20,21)

2.1.3 InChI Key

PPEBBOHQEAQKSW-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1OC2=C(O1)C=C(C=C2)C(CC(=O)C3=CC4=C(C=C3)OCO4)C(=O)O

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 88755-39-9

2. Chembl2000337

3. Runx1/eto Tetramerization-in-1

4. Nsc162496

5. Schembl16211954

6. Dtxsid40864143

7. Bdbm50392853

8. 2,3]dioxol-5-yl)-4-oxobutanoic Acid

9. Nsc-162496

10. Hy-151411

11. Cs-0611487

12. Ft-0627100

13. A937131

14. Butanoic Acid,4-bis[1,3-benzodioxol-5-yl]-4-oxo-

15. 2,4-bis(2h-1,3-benzodioxol-5-yl)-4-oxobutanoic Acid

2.3 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₁₄O₇
Molecular Weight	342.3 g/mol
XLogP3	2.4
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	5
Exact Mass	342.07395278 g/mol
Monoisotopic Mass	342.07395278 g/mol
Topological Polar Surface Area	91.3 Å²
Heavy Atom Count	25
Formal Charge	0
Complexity	522
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1